We are live on ! Find out more

1,470 hedge funds and large institutions have $103B invested in Merck in 2013 Q3 according to their latest regulatory filings, with 78 funds opening new positions, 568 increasing their positions, 619 reducing their positions, and 53 closing their positions.

New
Increased
Maintained
Reduced
Closed

47% more first-time investments, than exits

New positions opened: 78 | Existing positions closed: 53

36% more call options, than puts

Call options by funds: $1.25B | Put options by funds: $918M

1.31% more ownership

Funds ownership: 76.5%77.81% (+1.3%)

1% more capital invested

Capital invested by funds: $102B → $103B (+$1.23B)

1% more funds holding

Funds holding: 1,4591,470 (+11)

8% less repeat investments, than reductions

Existing positions increased: 568 | Existing positions reduced: 619

3% less funds holding in top 10

Funds holding in top 10: 120117 (-3)

Holders
1,470
Holders Change
+11
Holders Change %
+0.75%
% of All Funds
47.65%
Holding in Top 10
117
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-2.5%
% of All Funds
3.79%
New
78
Increased
568
Reduced
619
Closed
53
Calls
$1.25B
Puts
$918M
Net Calls
+$331M
Net Calls Change
-$98.6M
Name Holding Trade Value Shares
Change
Change in
Stake
NTCOC
226
Northern Trust Company of Connecticut
Connecticut
$42.2M +$1.51M +33,042 +4%
FRM
227
Foundation Resource Management
Arkansas
$41.8M -$72.7K -1,593 -0.2%
AII
228
AGF Investments Inc
Ontario, Canada
$41.6M -$3.97M -86,984 -9%
MIH
229
Madison Investment Holdings
Wisconsin
$41.2M +$94.7K +2,075 +0.2%
TU
230
TDAM USA
Ontario, Canada
$41.1M -$1.12M -24,533 -3%
AACR
231
ACR Alpine Capital Research
Missouri
$40.8M +$6.17M +135,045 +18%
TCM
232
Tetrem Capital Management
Manitoba, Canada
$38.9M -$5.92M -129,723 -13%
HCM
233
Highbridge Capital Management
New York
$38.1M +$30.6M +670,878 +400%
WCM
234
Wedge Capital Management
North Carolina
$38M +$1.36M +29,737 +4%
SAM
235
Silvercrest Asset Management
New York
$37.3M -$23.1M -506,403 -38%
EIM
236
ExxonMobil Investment Management
Texas
$37M -$2.92M -64,000 -7%
Balyasny Asset Management
237
Balyasny Asset Management
Illinois
$36.5M +$36.7M +804,429 New
NPA
238
Nichols & Pratt Advisers
Massachusetts
$36.4M -$1.56M -34,165 -4%
TAM
239
Todd Asset Management
Kentucky
$36.2M -$472K -10,335 -1%
WRF
240
Waddell & Reed Financial
Kansas
$35.7M -$15.3M -335,392 -30%
SCP
241
Seizert Capital Partners
Michigan
$35.1M +$1.59M +34,719 +5%
HighTower Advisors
242
HighTower Advisors
Illinois
$34.9M +$794K +17,392 +2%
PIA
243
Piedmont Investment Advisors
North Carolina
$34.7M -$28.7M -628,256 -45%
NLI
244
Nippon Life Insurance
Japan
$34.5M -$431K -9,429 -1%
CBOA
245
Commonwealth Bank of Australia
Australia
$34M -$2.12M -46,422 -6%
FWCM
246
Ferguson Wellman Capital Management
Oregon
$33.9M +$5.82M +127,370 +21%
WBC
247
Westpac Banking Corp
Australia
$33.7M -$21M -459,388 -38%
Mitsubishi UFJ Asset Management
248
Mitsubishi UFJ Asset Management
Japan
$33.1M +$1.01M +22,017 +3%
Royal London Asset Management
249
Royal London Asset Management
United Kingdom
$32.8M +$222K +4,868 +0.7%
GLA
250
Great Lakes Advisors
Illinois
$32.7M +$159K +3,493 +0.5%

MRK Hedge Fund Activity: Q3 2013 in Review

1,470 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q3 2013, worth a combined $103B — up 1.2% from $102B a quarter earlier.

Buyers outnumbered sellers: 78 funds opened new MRK positions and 53 closed out — a net gain of 25 holders — while 568 added to existing stakes and 619 trimmed.

The largest buyer was Eagle Asset Management, adding an estimated $192M. The largest seller was Fidelity Investments, cutting an estimated $612M.

  • 1,470 institutional investors held Merck (MRK) as of Q3 2013, up from 1,459 in Q2 2013.
  • Funds reported $103B of Merck stock for Q3 2013, up 1.2% quarter-over-quarter.
  • 78 funds opened new Merck positions in Q3 2013 and 53 closed out, a net change of +25 holders.
  • The largest Merck buyer in Q3 2013 was Eagle Asset Management, an estimated $192M added.
  • The largest Merck seller in Q3 2013 was Fidelity Investments, an estimated $612M sold.

Based on aggregated 13F filings for Q3 2013.